We provide you with 20 years of free, institutional-grade data for SLGL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SLGL. Explore the full financial landscape of SLGL stock.
| Reported Date | CIK | Ticker | Type |
|---|
Sol-Gel Technologies Ltd(NASDAQ:SLGL) 
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-dail...
Website: http://www.sol-gel.com
Founded: 1997
Full Time Employees: 61
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about SLGL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.